People with dementia in some parts of England are far more likely to be prescribed certain drugs than patients in other areas, according to new NHS England data reported by the Daily Mail.
The outlet says the disparity is substantial, with prescribing rates in some locations reported as up to nine times higher than in others. The reporting frames the pattern as a “postcode lottery,” suggesting that geographic variation affects access to treatments that could improve quality of life and potentially help patients live longer.
While the two accounts provide the same core figures and interpretation, they do not add further detail on which specific drugs are involved, what clinical or service factors drive the differences, or whether the data reflect differences in patient need versus prescribing practice. The coverage centers on the existence and scale of regional variation in dementia medication use, based on NHS England’s published figures.
